Atlas Trials

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

Clinical trial NCT06605378 · RECRUITING

Trial details

NCT number
NCT06605378
Sponsor
Ensoma
Status
RECRUITING
Study type
OBSERVATIONAL
Chronic Granulomatous Disease (CGD)
Start date
2024-11-18
Primary completion
2026-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.